| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |